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Summary
We have reported previously that syndecan-1 (Sdc1)-null
mice show delayed re-epithelialization after skin and
corneal wounding. Here, we show that primary
keratinocytes obtained from Sdc1-null mice and grown for
3-5 days in culture are more proliferative, more adherent
and migrate more slowly than wt keratinocytes. However,
the migration rates of Sdc1-null keratinocytes can be
restored to wild-type levels by replating Sdc1-null
keratinocytes onto tissue culture plates coated with
fibronectin and collagen I, laminin (LN)-332 or onto the
matrices produced by wild-type cells. Migration rates can
also be restored by treating Sdc1-null keratinocytes with
antibodies that block 6 or v integrin function, or with
TGF1. Antagonizing either 1 integrin function using a
function-blocking antibody or TGF1 using a neutralizing
antibody reduced wild-type keratinocyte migration more
than Sdc1-null keratinocyte migration. Cultures of Sdc1null keratinocytes accumulated less collagen than wild-type
cultures but their matrices contained the same amount of

Introduction
Syndecan-1 (Sdc1) is a single-pass, integral-membrane,
heparan-sulfate proteoglycan that is abundantly expressed by
epithelial keratinocytes early in development (Bernfield et al
et al., 1999). Although the Sdc1-null mouse was found to be
fertile and viable, when in vivo wound-healing studies were
conducted, phenotypes began to emerge (Stepp et al., 2002;
Gotte et al., 2002; Gotte et al., 2005). In cornea and skin of
Sdc1-null mice, wound healing was found to be delayed due
to slow re-epithelialization and increased inflammation.
These mice also showed increased cardiac dysfunction after
myocardial
infarction
associated
with
increased
inflammation, matrix metalloproteinase (MMP) expression
and function, and increased collagen disorganization
(Vanhoutte et al., 2007). Paradoxically, overexpression of
Sdc1 (Sdc/Sdc) in mice was also found to delay skin wound
healing because of reduced cell proliferation, granulation
tissue accumulation, and poor vascularization (Elenius et al.,

LN-332. The Sdc1-null keratinocytes expressed similar
total amounts of eight different integrin subunits but
showed increased surface expression of v6, v8, and
64 integrins compared with wild-type keratinocytes.
Whereas wild-type keratinocytes increased their surface
expression of 21, v6, v8, and 64 after treatment
with TGF1, Sdc1-null keratinocytes did not. Additional
data from a dual-reporter assay and quantification of
phosphorylated Smad2 show that TGF1 signaling is
constitutively elevated in Sdc1-null keratinocytes. Thus,
our results identify TGF1 signaling and Sdc1 expression
as important factors regulating integrin surface expression,
activity and migration in keratinocyte and provide new
insight into the functions regulated by Sdc1.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/120/16/2851/DC1
Key words: Syndecan-1, Keratinocytes, Integrins

2004). Together, these studies show that correct homeostasis
of stratified squamous epithelial tissues demands that Sdc1
levels are precisely regulated.
Of the four known syndecans, Sdc1 is the most abundant on
epithelial keratinocytes and can mediate cell-to-substrate
adhesion by its ability to bind to laminin  chains (Salmivirta et
al., 1994; Hoffman et al., 1998; Klass et al., 2000; Utani et al.,
2001; Okamoto et al., 2003). In addition, the Sdc1 cytoplasmic
domain has been shown to mediate cell spreading and migration
(Chakravarti et al., 2005). whereas Sdc4 has been shown to
interact with integrins at focal adhesions during wound healing
(Alexopoulou et al., 2007), less is known about how Sdc1
mediates migration. Sdc1 has been shown to interact functionally
with v integrins in various cancer cell lines (Beauvais et al.,
2004; Beauvais and Rapraeger, 2004; McQuade et al., 2006),
and a recent report by Hayashida and colleagues has shown that
expression of Sdc1 in epithelial keratinocytes is induced by
TGF1 through a protein kinase A (PKA)-dependent pathway
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(Hayashida et al., 2006). In response to injury in vivo, genes for
TGF1 and Sdc1 are upregulated in both epithelial and
mesenchymal cells, and the Sdc1 ectodomain is shed at wound
sites where the soluble molecule can regulate chemokine
function (Gotte and Echtermeyer, 2003; Tkachenko et al., 2004)
and modulate the activation of various MMPs (Kelly et al., 2000;
Steffensen et al., 2001; Momota et al., 2005). The role Sdc1
plays in cancer is complex and tissue specific, but recent studies
using Sdc1-null mice show that these mice are resistant to
mammary carcinogenesis (Alexander et al., 2002; McDermott et
al., 2007).
This study was undertaken to investigate the consequences of
the loss of Sdc1 on keratinocyte function in vitro, and to identify
alterations relevant to the delayed wound-healing phenotype
observed in cornea and skin in vivo. Our results show that the
loss of Sdc1 on activated keratinocytes enhances the overall
amount of several integrins at the keratinocyte surface, increases
adhesion, delays migration and causes an increase in the
constitutive level of TGF1-mediated gene expression.
Furthermore, the response of Sdc1-null keratinocytes to TGF1
is enhanced compared with that of wild-type
(wt) keratinocytes. We also found that the
reduced migration of Sdc1-null keratinocytes
can be overcome by replating the
keratinocytes on permissive substrates such
as fibronectin–collagen-I (FNCNI), LN-332,
matrix made from wt keratinocytes, or by
treating Sdc1-null keratinocytes with TGF1
or antibodies that block the function of 6 or
v integrins. Our results identify TGF1
signaling and Sdc1 expression as important
factors in activation and migration of
keratinocytes in vitro and in vivo.
Results
Sdc1-null keratinocytes reach highsaturation density and retain epithelial
morphology and expression of keratins
In this study, primary Sdc1-null
keratinocytes grew well in culture (Fig.
1A), and growth curves show that the Sdc1null keratinocytes had equivalent plating
efficiencies and reached confluence at the
same number of days after seeding (Fig.
1B). However, the Sdc1-null keratinocytes
achieved a higher population density than
wt keratinocytes due to increased
keratinocyte proliferation (Fig. 1C) and
increased packing of cells in and around
colonies (compare wt and Sdc1-null
keratinocytes in Fig. 1A). Since studies
using antisense methods (Kato et al., 1993)
and tumor cell lines (Bayer-Garner et al.,
2001; Kurokawa et al., 2006) have shown
that loss of Sdc1 can cause epithelial cells
to adopt a mesenchymal phenotype, wt and
Sdc1-null keratinocytes were assessed for
their localization of epithelial keratins (K1, K-5, K-6, K-10, and K-14), E-cadherin,
vimentin, and F-actin. Shown in Fig. 1D are
keratinocytes stained simultaneously with

an anti-K-14 antibody, phalloidin (for F-actin) and with the
nuclear marker DAPI. The Sdc1-null keratinocytes retained
epithelial morphology and continued to express K-14. They
also expressed E-cadherin and other epithelial keratins and
remained vimentin-negative (data not shown). However,
differences in cytoskeletal organization can be seen; Sdc1-null
keratinocytes showed thicker cortical actin bundles at cell
peripheries compared with wt keratinocytes.
Altered keratinocyte adhesion and delayed migration
accompany the loss of Sdc1 in keratinocytes
In vivo, re-epithelialization of wounds has been shown to be
delayed by 6-8 hours in Sdc1-null mice (Stepp et al., 2002); in
the current study, adhesion and migration studies were
performed to determine whether reduced migration rates after
wounding in vivo correlated with altered properties of the
keratinocytes in vitro. After 3 days in culture, equal numbers
of wt and Sdc1-null keratinocytes were harvested and allowed
to adhere to ECM-coated substrates for 60 minutes (Fig. 2A).
Adhesion to all the matrices tested – fibronectin (FN),

Fig. 1. Although loss of Sdc1 alters keratinocyte growth characteristics, Sdc1-null
keratinocytes retain their epithelial morphology and keratin expression. (A,B) Equivalent
numbers of primary wt (+/+) and Sdc1-null (–/–) keratinocytes were plated out and grown
for the times indicated; in A keratinocytes are viewed with phase-contrast optics at 3 days
after being placed in culture, and in B the numbers of adherent primary +/+ and –/–
keratinocytes were counted at the indicated days. Data are plotted as the mean ± s.e.m.; *,
significantly more Sdc1-null keratinocytes per dish than wt keratinocytes at days 3 and 10.
Bar in A, 10 m. (C) Studies using [3H]thymidine showed that at day 7, Sdc1-null
keratinocytes proliferated more than wt keratinocytes, even after controlling for
differences in keratinocyte density. (D) Triple-labeling using FITC-labeled phalloidin
(green) for F-actin, K14 (red) for intermediate filament protein keratin 14, and DAPI
(blue) for nuclei in +/+ keratinocytes (a-d) and on –/– keratinocytes (e-h). The localization
of K14 appears similar in wt and Sdc1-null keratinocytes. Sdc1-null keratinocytes show
thicker cortical actin filament bundles that localized prominently at keratinocyte
peripheries compared with wt keratinocytes. *, regions shown magnified in d and h to
better emphasize the actin cortical filaments. Bar in D, 4 m (a-c and e-g) and 1.3 m (d
and h).
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keratinocytes on purified matrices could be owing to a
combination of increased attachment and spreading of the
Sdc1-null keratinocytes. When spreading studies were
performed at 60 minutes after plating, there were no significant
differences in keratinocyte spreading (data not shown). Since
the adhesion assays presented in Fig. 2A were performed on
keratinocytes 60 minutes after plating, the increased adhesion
of the Sdc1-null keratinocytes seen is probably due to increased
keratinocyte attachment.
The attachment differences seen between the wt and Sdc1null keratinocytes could impact the migratory behavior of
Sdc1-null keratinocytes. To assess this, keratinocytes were
seeded and grown for 5 days, and random movement of
keratinocytes within wells in 24-well plates was assessed using
time-lapse microscopy. At day 5, the Sdc1-null keratinocytes
were found to migrate significantly slower than wt
keratinocytes, as seen in the average velocities presented in
Fig. 2B and the representative tracks presented in Fig. 2C.
When data were evaluated for differences in persistence indices
(net migration per total migration), no differences between wt
and Sdc1-null keratinocytes emerged.

Fig. 2. Keratinocyte adhesion and time-lapse migration studies show
that Sdc1-null keratinocytes adhere better and migrate poorly
compared with wt keratinocytes, but only when migrating on matrix
they produce themselves. (A) Cell adhesion studies were performed
on equal numbers of wt and Sdc1-null keratinocytes, which were
allowed to adhere on wells coated with fibronectin (FN), vitronectin
(VN), laminin-111 (LN-111), collagen I (CN-I) and collagen IV
(CN-IV). Note that the Sdc1-null keratinocytes are significantly more
adherent than the wt keratinocytes to all ECM molecules tested.
(B,C) Cell migration was assessed in time-lapse experiments in wt
and Sdc1-null keratinocytes 5 days after initial plating. For details on
the quantification, see Materials and Methods. Velocity
measurements for wt and Sdc1-null keratinocytes are presented in B.
*P<0.05. Typical tracks (red) of 15 keratinocytes are shown
superimposed over final relief-contrast images of wt and Sdc1-null
keratinocytes in C. Bar, 10 m. (D) Velocities of wt and Sdc1-null
keratinocytes were compared after replating onto FNCNI matrix and
onto LN-332 as well as onto matrices deposited by each keratinocyte
genotype. Data show that after replating, Sdc1-null keratinocytes
migrated more slowly than wt keratinocytes but only when replated
on the Sdc1-null keratinocyte matrix.

vitronectin (VN), laminin-111 (LN-111), collagen I (CNI) and
collagen IV (CNIV) – was enhanced in the Sdc1-null
keratinocytes compared with the wt keratinocytes; increased
adhesion ranged from 3.3-fold higher for adhesion to VN to
1.5- to 2.0-fold higher for adhesion to the other matrix ligands.
Because adhesion assays measure both cell attachment and
spreading, the increased adhesion of the Sdc1-null

Altering the composition of the matrix the Sdc1-null
keratinocytes are seeded upon can restore their
migration rate to that of wt keratinocytes
The slower velocity of the Sdc1-null keratocytes could be
caused by altered cytoskeletal dynamics or by their increased
attachment to their substrate. To test this we evaluated cell
migration after replating keratinocytes onto other matrices;
data are presented in Fig. 2D. Keratinocytes were grown for 3
days and replated on purified FN-CNI or the LN-332-rich
matrix secreted by 804G cells; as controls, migration rates of
keratinocytes were also obtained for keratinocytes at day 4
after initial seeding. Day 3 keratinocytes were also replated
onto wells that contained matrix (prepared as described in
Materials and Methods) that had been produced and deposited
by either wt or Sdc1-null keratinocytes. Triplicate wells were
then used to track keratinocyte migration in time-lapse
experiments. As expected, the day-4 Sdc1-null keratinocytes
migrated more slowly than wt keratinocytes. When Sdc1-null
keratinocytes were replated onto FN-CNI, LN-332 or onto the
matrix deposited by wt keratinocytes, their migration rate was
restored to that of wt keratinocytes; however, when replated
onto their own matrix, they continued to migrate more slowly.
Wild-type keratinocytes migrated at rates faster than those of
control keratinocytes when replated onto day-3 Sdc1-null
keratinocyte matrix. Therefore, these data show that the Sdc1null keratinocyte matrix can support optimal cell migration
when keratinocytes express Sdc1 and indicate that there is
something distinct about the way the Sdc1-null keratinocytes
interact with their matrix that reduces their ability to migrate
quickly.
To determine whether there are differences in the
organization of the wt and Sdc1-null matrices, we assessed the
accumulation of collagen in keratinocyte cultures using a
Sirius Red dye binding assay (Heng et al., 2006).
Keratinocytes that had been used for tracking studies were
immediately fixed and the collagen accumulation within the
cultures was assessed. After data normalization for differences
in keratinocyte numbers per well, we found that significantly
less collagen was present within the wells of the Sdc1-null
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Fig. 3. Sdc1-null keratinocytes produce a
matrix distinct from that made by wt
keratinocytes. (A) Sirius Red dye binding
assay to measure collagen accumulation in
the wt and Sdc1-null cultures shows that the
day after the keratinocytes had been tracked,
Sdc1-null keratinocyte cultures had
accumulated significantly less collagen per
keratinocyte compared with wt
keratinocytes. (B) Matrix preparations
identical to those used in the experiments
described in Fig. 2D were extracted as
described, normalized and run on 4-20%
gels that were silver-stained. Highmolecular-mass proteins accumulated in the
matrices, but there were no major
differences between the amount of highmolecular-mass matrix deposited by the wt
and Sdc1-null keratinocytes. The lower
molecular mass bands are keratins, which
stick non-specifically to the matrix after
keratinocytes are lysed. The control extract
shows those proteins deposited on wells
which remain after ammonium hydroxide
treatment of wells that had been coated with
FN-CNI and fed serum-containing medium.
(C) Immunoblots of the same matrix
preparations shown in B normalized by cell
count and probed for LN-332 using the J18
antibody showed similar patterns for LN-332 unprocessed (unp) and processed (prc) 332 chains for matrices deposited by wt and Sdc1-null
keratinocytes. (D) Immunofluorescence microscopy using the J18 antibody on matrix preparations from cultures of wt and Sdc1-null
keratinocytes. (a,d) 20 images taken of wt and Sdc1-null keratinocytes; asterisks indicate elongated clear areas lacking LN-332 surrounded by
areas positive for LN-332. In b and e, asterisks indicate regions shown at higher resolution. (c and f) Additional high-resolution images of wt
and Sdc1-null keratinocyte matrices, respectively. Arrows in b,c,e,f indicate ordered streaks that are more prominent in Sdc1-null matrix than in
wt matrix; arrowheads indicate amorphous cloud-like staining present in wt matrix but largely absent in Sdc1-null keratinocytes. Bar, 6 m for
a,d, 2 m for b,c,e,f.

keratinocytes (Fig. 3A). To determine whether there were
differences in the overall profile of proteins present in the
matrices deposited by wt or Sdc1-null keratinocytes, we
prepared matrices using methods identical to those used for
the experiments shown in Fig. 2D, and ran extracts normalized
for keratinocyte numbers onto 4-20% SDS-polyacrylamide
gels that were then silver stained (Fig. 3B). Since one of the
most abundant proteins present in these matrix preparations is
LN-332, we also blotted these extracts for detection of LN332 using the J18 antibody, which recognizes both
unprocessed and processed LN-3, 3, and 2 chains (Fig.
3C). We did not see any difference in the overall amounts of
high molecular weight molecules assembled into matrix at
days 5 and 7 by wt or Sdc1-null keratinocytes. We found no
difference in the amount of LN-332 present in these matrices;
differences in LN-332 processing cannot be quantified without
mouse LN-332-subunit-specific antibodies. Next, we looked
directly at the LN-332 organization within matrices produced
by the wt and Sdc1-null keratinocytes by performing
immunolocalization experiments on matrix preparations using
the J18 antibody (Fig. 3D). Data confirmed that the wt and
Sdc1-null keratinocytes deposited similar amounts of LN-332enriched matrix. However, Sdc1-null keratinocytes deposited
LN-332 into more highly ordered (arrowhead) arrays oriented
in the direction of keratinocyte migration, whereas LN-332
left behind by wt keratinocytes was organized into cloud-like
aggregates (arrowheads, Fig. 3D).

4 integrin regulates migration to a greater extent in
Sdc1-null keratinocytes than in wt keratinocytes
Thus far, our data show that Sdc1-null keratinocytes migrated
more slowly than wt keratinocytes owing to factors involving
their ability to interact with the matrix they deposit. 64
integrin is known to interact with LN-332 and has been
implicated, together with 31 integrin, in mediating
keratinocyte migration (Belkin and Stepp, 2000). To test
directly whether increased activity of integrins on the Sdc1-null
keratinocytes contributes to their reduced migration rate, we
repeated time-lapse experiments using integrin-functionblocking antibodies: GoH3 for 6, 9EG7 for 1 integrins and
RMV-7 for v integrins. Data are presented in Fig. 4A as the
fold change in velocity relative to untreated wt keratinocytes.
Antagonizing the activity of either 6 or v integrins fully
restores velocity of Sdc1-null keratinocytes to the same or
slightly higher rate than that of wt keratinocytes. Antagonizing
1 integrins slows down migration rates of both wt and Sdc1null keratinocytes but the affect is more profound in wt
keratinocytes where migration rates were reduced by just over
60% of the rates seen in untreated or control-IgG-treated wt
keratinocytes. For Sdc1-null keratinocytes, the 1 antagonist
decreased migration rates by ~30%, not significant compared
with that of untreated Sdc1-null keratinocytes. Thus, Sdc1-null
keratinocytes migrate at slower rates due to reduced 1 integrin
activity and/or increased 64 and/or v integrin activity.
We went on to examine localization of 3 and 4 integrin
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Fig. 4. The velocity of Sdc1-null keratinocytes can be
restored to that of wt keratinocytes by addition of
function-blocking antibodies against 4 or v integrins.
(A) Time-lapse microscopy analyses were repeated on
day 3 wt and Sdc1-null keratinocytes using integrin
function-blocking antibodies at concentrations of 25
g/ml added to serum-containing medium. Data are
expressed as fold changes in velocity compared with
untreated wt keratinocytes to facilitate comparisons
between experiments. Control studies were performed
using isotype specific antibodies. Note that the 1
integrin antagonist (9EG7) inhibited wt keratinocyte
migration rates significantly by ~60% whereas it
inhibited Sdc1-null keratinocyte migration by only
~30% compared with untreated Sdc1-null keratinocytes,
a difference which was not significant. By contrast,
antagonizing either 64 integrin using GoH3 or all v
integrins using RMV-7 allowed Sdc1-null keratinocytes
to migrate at rates similar to those of wt keratinocytes.
(B) 4 integrin and LN-332 were simultaneously
localized in day 3 wt and Sdc1-null keratinocytes. a,b
and e,f show double-staining of actively migrating wt
and Sdc1-null keratinocytes, respectively, whereas c,d
and g,h show more stationary keratinocytes lacking LN332 trails. Note the closer association between 4
integrin and LN-332 at the edges of the migrating Sdc1null keratinocytes in e and f (white arrows) compared
with the wt keratinocytes. Bar, 5 m.

in the wt and Sdc1-null keratinocytes. Finding only subtle
differences in 31 localization (data not shown), we focused
on colocalization studies of LN-332 and 4 integrin in wt and
Sdc1-null keratinocytes. Whereas there are a wide variety of
keratinocyte morphologies and 4 integrin and LN-332
localization profiles in primary keratinocyte cultures,
differences in 4 integrin localization and cell morphology
emerged when we compared localization of these two proteins
in actively migrating wt and Sdc1-null keratinocytes
surrounded by prominent LN-332 trails (Fig. 4B). Migrating
wt keratinocytes were smaller and less uniform in shape
compared with Sdc1-null keratinocytes, and there was less 4
integrin present at cell peripheries. LN-332 and 4 integrin are
present beneath the cell nucleus in both migrating and
stationary wt and Sdc1-null keratinocytes. In migrating Sdc1null keratinocytes, we were frequently able to see close
association of 4 integrin with LN-332 at cell peripheries, and
Sdc1-null keratinocytes were less uniformly round in shape.
For both the wt and Sdc1-null keratinocytes, those that were
not actively moving, as evidenced by the absence of LN-332
trails, were more round with less 4 integrin present at cell
peripheries. 4 integrin was present on the basal surface and
surrounding the perinuclear region and, although it appeared
more organized in the Sdc1-null keratinocytes, there was
significant variability in this phenotype.
v integrins, especially v6 and v8, are involved in
mediating the activation of TGF1 signaling in epithelial cells
(Sheppard, 2005). Little is known about how the activity of v

integrins might affect keratinocyte migration. TGF1 has long
been known to alter the surface expression of integrins,
including those containing the v and 1 subunits (Gailit et
al., 1994; Decline et al., 2003). Furthermore, Sdc2 has recently
been shown to facilitate binding and activity of TGF1 on cell
surfaces (Chen et al., 2004), and TGF1 signaling has been
shown to induce Sdc1 expression through a PKA-dependent
pathway (Hayashida et al., 2006). To determine whether
TGF1 played a role in mediating the migration rates of the
wt and Sdc1-null keratinocytes, we treated keratinocytes with
a neutralizing antibody against TGF1 (TGF1NA) or with
exogenous addition of TGF1, and measured keratinocyte
migration rates using time-lapse microscopy. Data are
presented in Fig. 5A,B. Addition of the TGF1NA to both wt
and Sdc1-null keratinocytes reduced cell migration rates of
both genotypes significantly; control IgGs at the same
concentration had no affect on the rate of cell migration (data
not shown). Despite the fact that TGF1NA reduced the
migration rates of both wt and Sdc1-null keratinocytes, it had
a more profound affect on migration rates of wt keratinocyte
because it reduced wt migration to ~55% that of untreated wt
control keratinocytes and reduced migration of Sdc1-null cells
by ~30% compared with untreated Sdc1-null keratinocytes
(Fig. 5A). These data suggest that TGF1 signaling plays a
role in regulating the overall velocity of keratinocytes in
primary culture, and further suggests that differences between
wt and Sdc1-null keratinocytes in TGF1 signaling exist.
Consistent with these data, addition of 0.25 ng/ml TGF1 to
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TGF1NA-treated wt and Sdc1-null keratinocytes
were similar in overall morphology and 4
integrin localization compared with untreated
keratinocytes (compare Fig. 5C with Fig. 4B) and
both genotypes showed increased close association
of LN-332 with 4 integrin. The migrating
TGF1-treated wt keratinocytes (Fig. 5Ce,f) were
more spread out than untreated wt keratinocytes
(Fig. 4Bb), whereas the migrating TGF1-treated
Sdc1-null keratinocytes (Fig. 5Cg,h) were less well
spread out compared with migrating untreated
Sdc1-null keratinocytes (Fig. 4Be,f). Also, the
close association of 4 integrin and LN-332 at the
keratinocyte peripheries seen in migrating
untreated Sdc1-null cells was decreased. These
data suggest that treatments that restore Sdc1-null
keratinocyte migration rates to levels similar to
those of wt keratinocytes reduce the close
association of 4 integrin with LN-332, whereas
treatments that reduce wt and Sdc1-null
keratinocyte migration enhance the close
association of 4 integrin with LN-332.
Cell-surface integrins are constitutively
elevated in Sdc1-null keratinocytes and do
not change in response to TGF1 treatment
The increased attachment and reduced migration
rates observed in the Sdc1-null keratinocytes, and
the changes in migration that accompany
activation of TGF1 signaling by growth factor
treatment could be due to altered expression of
integrins in keratinocytes lacking Sdc1. To test
this, we assessed total integrin expression in wt
Fig. 5. Disruption and activation of TGF1 signaling has distinct effects on the
and Sdc1-null keratinocytes and found that, for
migration rates of wt and Sdc1-null keratinocytes. (A) wt and Sdc1-null
each of the eight keratinocyte integrin subunits
keratinocytes were grown for 3 days, after which keratinocytes were treated with
assessed
by
immunoblotting
and
after
a TGF1 neutralizing antibody overnight and then tracked by time-lapse
normalization for total protein and/or actin, there
microscopy the next day. Data show that neutralizing TGF1 reduced wt
were no differences in expression in wt versus
keratinocyte migration rates by over 50% but inhibited Sdc1-null keratinocyte
Sdc1-null keratinocytes (see supplementary
migration by less than 30% compared with untreated or control IgG treated Sdc1material Fig. S1). Expression of 9 integrin in both
null keratinocytes. (B) wt and Sdc1-null keratinocytes were grown for 3 days,
wt and Sdc1-null keratinocytes was downregulated
after which keratinocytes were treated with 0.25 or 2.5 ng/ml TGF1 overnight
after keratinocytes were placed in culture and,
and then tracked the next day. The migration rates of the Sdc1-null keratinocytes
were restored to those of wt keratinocytes after treatment with 0.25 ng/ml
therefore,
could
not
be
detected
by
TGF1. Further, the Sdc1-null keratinocytes migrated significantly faster than the
immunoblotting.
wt keratinocytes when given 2.5 ng/ml TGF1. Whereas lower concentration of
Integrins are present within intracellular
TGF1 stimulated wt keratinocyte migration rates, higher concentration did not.
compartments as well as on the cell surface. To
*P<0.05; grey line highlights values above untreated wt controls.
analyze integrin surface expression on wt and
(C) Localization of LN-332 and 4 integrin in migrating wt and Sdc1-null
Sdc1-null keratinocytes, we initially used flow
keratinocytes 24 hours after treatment of keratinocytes with either TGF1cytometry. Data are presented in Fig. 6A for 1
neutralizing antibody (a-d) or with 0.25 ng/ml of TGF1 (e-f). Bar, 5 m.
and 4 integrins and indicate 1.2 and 1.6 times
more, respectively, of both integrins on the surface
both wt and Sdc1-null keratinocytes increased their migration
of untreated Sdc1-null keratinocytes compared with untreated
rates. Whereas wt keratinocytes were no longer able to increase
wt keratinocytes. Since there are few antibodies available that
their migration rates in response to higher doses (2.5 ng/ml) of
detect extracellular epitopes of mouse integrins, we measured
TGF1, Sdc1-null keratinocytes migrated faster than untreated
surface integrins by surface-labeling keratinocytes in
keratinocytes in response to the higher dosage of growth factor
suspension at 4°C using biotinylation, followed by
(Fig. 5B).
immunoprecipitation (IP) with integrin antibodies and
To get a better idea about how TGF1 affects migration of
detection of biotin-labeled integrin heterodimers using
wt and Sdc1-null keratinocytes, we visualized 4 integrin and
horseradish peroxidase (HRP)-conjugated avidin. After
LN-332 in wt and Sdc1-null keratinocytes that had been treated
demonstrating that the biotinylation efficiency of the Sdc1-null
either with TGF1NA or with 0.25 ng/ml TGF1 (Fig. 5C).
keratinocytes was similar to that of the wt keratinocytes – using

Defects in Sdc1-null keratinocytes

2857

Journal of Cell Science

labels primary amine groups and the numbers of
biotins added per integrin molecule vary
between the different subunits. As a result,
frequently only one of the two subunits was
detected in the unreduced mini-gels as shown in
Fig. 6B; data were quantified and are shown in
Fig. 6C.
Comparing integrin surface expression in wt
and Sdc1-null keratinocytes, we show that Sdc1null keratinocytes expressed significantly (1.3 to
1.5 times) more 4, v, 6 and 8 integrins than
wt keratinocytes. Because the difference
between the surface expression of integrins on
the wt and Sdc1-null keratinocytes was less than
twofold, these experiments were repeated seven
times to determine statistical significance. The
increase in 2 integrin was not significant and
3 integrin expression was not elevated in the
Sdc1-null keratinocytes (Fig. 6C). In wt
keratinocytes but not in Sdc1-null keratinocytes,
TGF1
significantly
enhanced
surface
expression of several integrins including 4, 2,
v, 6 and 8, with increases ranging from 1.5
times higher (2) to over 2 times higher (v).
Only 3 integrin expression at the keratinocyte
surface remained at similar levels on both
control and TGF1-treated wt and Sdc1-null
keratinocytes. Adding 2.5 ng/ml TGF1 to day3 cultures of wt and Sdc1-null keratinocytes
yielded differences in integrin expression
similar to those seen for 0.25 ng/ml (data not
shown). These data show that adding TGF1,
which increases migration in both wt and Sdc1null keratinocytes, also increased integrin
surface expression in wt keratinocytes.
However, Sdc1-null keratinocytes showed
elevated levels of several integrins before
treatment with TGF1, and those levels were
not altered in response to TGF1.
Fig. 6. Sdc1-null keratinocytes have increased expression of several different
integrins on their surface but, unlike wt keratinocytes, they do not increase their
integrin surface expression in response to TGF1. (A) Flow cytometry analysis on
unfixed isolated wt and Sdc1-null keratinocytes revealed increased surface
expression of 1 and 4 integrins, as determined using Student’s t-test (P< 0.05).
(B) Tests of biotinylation efficiency show that the amount of biotin incorporated per
ng total protein for wt and Sdc1-null keratinocytes is similar, as is the overall profile
of biotinylated proteins. (C,D) Biochemical analyses of surface integrins using
biotinylation and immunoprecipitation reveals elevated levels of several integrins in
untreated Sdc1-null keratinocytes, excluding 3 integrin; the increase seen for 2
integrin was not significant. Treating wt and Sdc1-null keratinocytes with 0.25 ng/ml
TGF1 for 24 hours significantly increased the expression in wt keratinocytes of all
the integrins tested, excluding 31, but had no significant effect on integrin surface
expression by the Sdc1-null keratinocytes. Numbers in C represent fold increase in
surface integrins in the untreated and TGF1-treated Sdc1-null keratinocytes
relative to wt keratinocytes.

a dot-blot technique and by assessing biotinylation of total
protein extracts from both wt and Sdc1-null keratinocytes (Fig.
6B) – extracts were normalized based on equal amounts of total
protein, and IP was performed. Although under the conditions
used for the IPs both  and  subunits were pulled down, biotin

Sdc1-null keratinocytes have constitutively
elevated TGF1-mediated signaling and
respond to TGF1 over a wider range of
concentrations than wt keratinocytes
All of the integrins whose surface expression in
wt keratinocytes was altered by addition of 0.25
ng/ml TGF1, namely 2, v, 4, 6 and 8
integrins, were also surface-elevated in the
Sdc1-null keratinocytes prior to TGF1
treatment. These data, together with the data
showing different migratory responses to high
concentrations of TGF1, suggest the
possibility that the Sdc1-null keratinocytes have
alterations in TGF1 signaling.
To assess the possibility of defective TGF1
signaling, we investigated the ability of
increasing TGF1 concentrations (0.015 ng to 1 ng/ml) to
inhibit DNA synthesis. Like wt keratinocytes, Sdc1-null
keratinocytes ceased proliferation with a similar dose response
when treated with increasing concentrations of TGF1 (Fig.
7A). We then looked in more detail at TGF1-induced gene
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expression by using a dual reporter assay, we assessed the
ability of TGF1 to induce transcription of Smad4-dependent
promoters. Data are presented in Fig. 7B for keratinocytes
assayed 20 hours after TGF1 treatment and expressed as
levels of TGF1-induced gene expression after controlling for
differences in transfection efficiency. Similar results were
obtained 6 hours after TGF1 treatment (data not shown). Both
wt and Sdc1-null keratinocytes had detectable TGF1mediated gene expression prior to the addition of TGF1;
however, the constitutive level of TGF1-mediated gene
expression in the Sdc1-null keratinocytes (6.7-fold) was
significantly greater than that in wt keratinocytes (3.9-fold).
The increase in levels of TGF1-induced gene expression
measured after addition of 0.5 ng/ml TGF1 was 47-fold in
Sdc1-null keratinocytes compared with 30-fold in wt
keratinocytes. Increasing the concentration of TGF1 in the
medium from 0.25 to 0.50 ng/ml increased TGF1-induced
gene expression in Sdc1-null keratinocytes but had no affect on
wt keratinocytes.
The data from the dual-reporter assay show that, (1) Sdc1null keratinocytes have increased constitutive signaling
through the TGF1 pathway and, (2) Sdc1-null keratinocytes
respond to levels of TGF1 above those that elicit a
transcriptional or migratory response in wt keratinocytes. We
confirmed the data regarding increased constitutive signaling
by assessing Smad2 phosphorylation in wt and Sdc1-null
keratinocytes. Prior to the addition of exogenous TGF1,
Sdc1-null keratinocytes showed elevated levels of
phosphorylated Smad2 (P-Smad2) compared with those in wt

keratinocytes (Fig. 7C). Addition of TGF1 induced a
reproducible increase in P-Smad2 in wt keratinocytes within
15 minutes, which was sustained until at least 60 minutes later.
By contrast, the Sdc1-null keratinocytes showed no change in
P-Smad2 levels in response to the addition of TGF1.
Next, we performed semi-quantitative RT-PCR to assay the
levels of mRNAs known to be upregulated by TGF1 in wt
keratinocytes using untreated day-3 wt and Sdc1-null
keratinocytes. Data are presented numerically in Table 1;
supplementary material Fig. S2 shows the gels. After
normalizing against the mRNA levels in wt keratinocytes, we
saw increased levels of several TGF1-inducible mRNAs,
including proteoglycans-like biglycan (1.8 times) and lumican
(1.8 times), as well as matrix molecules including collagens
1-I (1.8 times) and 2-VI (1.9 times) despite the fact that we
had not given the keratinocytes TGF1. Thrombospondin and
Mmp9 mRNAs also showed a modest (1.5 times and 1.3 times,
respectively) increase in Sdc1-null keratinocytes. These mRNA
studies support the conclusion that the Sdc1-null keratinocytes
were engaged in an elevated level of constitutive TGF1
signaling.
We next considered whether the overall production of
TGF1 by Sdc1-null keratinocytes was greater than that of wt
keratinocytes. Evaluating total TGF1 accumulation in
conditioned media we observed, at the earliest time point
detectable, that Sdc1-null keratinocytes secreted ~1.3 times
more total TGF1 per cell than wt keratinocytes. By day 15,
the Sdc1-null keratinocytes had secreted about two times more
total TGF1 than had the wt keratinocytes (Fig. 7D). When the

Fig. 7. TGF1-mediated signaling is altered in
Sdc1-null keratinocytes. (A) Addition of
increasing concentrations of TGF1 to wt and
Sdc1-null keratinocytes inhibits keratinocyte
proliferation with both genotypes showing
identical responses. (B) A dual reporter assay was
used to determine the fold induction of
transcription of a TGF1-induced promoter
(Smad4) compared with a control promoter
(transketolase) 20 hours after wt and Sdc1-null
keratinocytes were treated with 2 ng TGF1, as
described in Materials and Methods. Note that the
baseline of TGF1-mediated gene transcription
for untreated keratinocytes was significantly
higher for Sdc1-null keratinocytes, and that Sdc1null keratinocytes had higher TGF1-induced
gene expression at all concentrations of TGF1
tested; at 20 hours, these increases were
significant for 250 and 500 ng TGF1. (C)
Smad2 phosphorylation was measured directly in
wt and Sdc1-null keratinocytes before and after
TGF1 addition. In response to TGF1, wt
keratinocytes showed an increase in P-Smad2,
whereas Sdc1-null keratinocytes did not. (D)
Amount of total TGF1 secreted into conditioned
media was assessed via ELISA assay at the times
indicated and data expressed as picogram (pg) per
106 cells. (E) The amount of active TGF1
secreted into conditioned medium as well as in
cell extracts was assessed using a standard mink
lung epithelial reporter cell assay as described
(see Materials and Methods); data are expressed
in relative luciferase units.
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Table 1. Semi-quantitative RT-PCR analyses of expression
of TGF1-induced mRNAs
Biglycan
Decorin
Fibromodulin
Lumican
Mmp9
Collagen 1-I
Collagen 1-IV
Collagen 1-V
Collagen 2-VI
Thrombospondin
Tubulin

+/+

–/–

1±0.26
1±0.08
1±0.12
1±0.19
1±0.06
1±0.11
1±0.15
1±0.04
1±0.04
1±0.13
1±0.03

1.8±0.04 *
1.2±0.02
1.3±0.05
1.8±0.06*
1.3±0.04
1.8±0.07*
1.1±0.01
1.1±0.01
1.9±0.07*
1.5±0.02
1.08±0.04
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Data indicate the fold increase in day-3 cultures of Sdc1-null keratinocytes
(–/–) relative to wt cells (+/+) ± s.e. (wt control values were set as 1). *,
values for which mRNA differences in expression were significant calculated
using the Mann-Whitney test P=0.05.

amount of active TGF1 in the conditioned medium was also
assessed by using a standard cell assay with luciferase-tagged
transfected mink lung epithelial cells (TMLCs) (Fig. 7E), 1.6
times more active TGF1 per 106 cells was seen in the medium
of Sdc1-null keratinocytes than in medium of wt keratinocytes.
In addition, we also assessed the amount of active TGF1
present in keratinocyte extracts obtained from the wt and Sdc1null keratinocytes (Fig. 7E). At day 14, the extracts obtained
from the Sdc1-null keratinocytes showed amounts of active
TGF1 similar to those from wt keratinocytes.
Discussion
In this study, we show that cultured Sdc1-null keratinocytes
migrate more slowly than wt keratinocytes, seemingly because
of factors related to their interaction with and the assembly of
their extracellular matrix. We further show that Sdc1-null
keratinocytes have elevated constitutive TGF1 signaling and
also respond to concentrations of TGF1 above those that elicit
responses in wt keratinocytes. By 3 days in culture, the Sdc1null keratinocytes expressed higher levels of integrins on their
surface than wt keratinocytes, despite the fact that both wt and
Sdc1-null keratinocytes isolated directly from wt and Sdc1-null
mouse skin showed similar levels of integrins on their surfaces.
When we evaluated the migratory phenotypes of wt and Sdc1null cells after treatment of cells with antibodies that block 6,
1 and v integrins, we were able to show involvement of vfamily integrins in mediating 64 activity.
Association of Sdc1 with the v-integrin family in wt cells
promotes 64-integrin-mediated migration over cell
adhesion
When we inhibited 1 integrin function the rate of migration
was reduced for both the wt and Sdc1-null keratinocytes, but
the difference between wt and Sdc1-null keratinocyte velocities
after blocking 1-family integrin function was still significant:
Sdc1-null keratinocytes still migrated slower than wt cells
when they were forced to use v-family integrins and 64 as
their primary cell-to-substrate adhesions. This result implicates
either v-family integrins or 64 as causative in the delayed
migration rates of Sdc1-null keratinocytes. Blocking 6
function restored migration rates of Sdc1-null keratinocytes to
the same levels as in wt cells; thus, when Sdc1-null

Fig. 8. Cartoon highlighting results from the studies using integrinfunction-blocking antibody. PM, plasma membrane; N,nucleus; v,
integrin heterodimers that contain the v subunit, are expressed in
keratinocytes and include integrins v5, v6 and v8; 1,
integrin heterodimers that contain the 1 subunit, are expressed in
keratinocytes and include integrins 21, 31 and 51 (see
supplementary material Fig. S1 for expression profiles of total
keratinocyte integrins and Fig. 6B for surface integrins).

keratinocytes are forced to use v-family and 1-family
integrins, they no longer experience any delay in their
migration rate. For 64 to reduce Sdc1-null keratinocyte
migration, the activity of v family integrins is needed.
Blocking v function restored keratinocyte migration rates in
Sdc1-null cells but, unlike 6 integrin, the -integrin
antagonist reversed the phenotype so that the Sdc1-null
keratinocytes were migrating faster than wt keratinocytes.
Thus, when Sdc1-null keratinocytes depend on 64 and 1family integrins for their migration, they migrate faster than
similarly treated wt cells. Taken together, these data implicate
v-family integrins as positive regulators of the adhesive
functions of 64. In wt keratinocytes, Sdc1 cooperates with
v integrins to decrease the adhesion and increase the
migratory activity of 64.
Our data show that Sdc1 on keratinocytes modulates the
function of 64 integrin by facilitating detachment from LN332 matrices during migration and it does so by indirectly
interacting with v-family integrins. A model summarizing
these results is presented in Fig. 8. Incorporated into the model
is our knowledge that in normal and migrating epithelial tissues
in skin and cornea, Sdc1 is not localized at the basal membrane
of the basal keratinocyte surface where 64 is found but,
rather, is present on basolateral and apical membranes and in
endosomal compartments (Stepp et al., 2002). Although during
wound healing the localization of 64 extends to the
basolateral membrane surfaces, it remains enhanced at the
basal surface where Sdc1 is absent. Thus, any effect that Sdc1
has in mediating keratinocyte adhesion and migration would
have to be a regulatory one.
Although other studies have suggested that 64 integrin
affects migration by altering LN-332 matrix assembly
(Rabinovitz et al., 2001; Sehgal et al., 2006), our study is the
first to implicate TGF1 and Sdc1 in this process. Conversion
of 64 integrin from a state that mediates migration to one
that mediates firm adhesion has been shown to be regulated by
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phosphorylation of the integrin 4 subunit by the EGF receptor
(Mainiero et al., 1996; Mariotti et al., 2001). Sdc1 is known to
associate with LN  chains (Hoffman et al., 1998), but recently
a study by Ogawa and colleagues has shown that Sdc1 also
associates with a fragment derived from the LN-332 2 chain
and this complex inhibits phosphorylation of 64 integrin
(Ogawa et al., 2007). Interaction between Sdc1 and the LN 2
fragment causes integrin 64 to promote adhesion over
migration. These data are consistent with previous data
showing that proteolytic processing of LN-332 favors stable
adhesion, whereas unprocessed forms of the molecule favor
migration (Goldfinger et al., 1999). Ogawa and colleagues have
also indicated that the interaction between Sdc1 and integrin
64 is indirect (Ogawa et al., 2007). Realizing that integrin
64 and Sdc1 generally exist in separate domains on the
plasma membrane, we propose that Sdc1 interacts with vfamily integrins on basolateral and apical membranes such that
both molecules are sequestered from 64 leaving it available
to exist in its migratory state, shown by others to be
phosphorylated by the EGF receptor. In Sdc1-null
keratinocytes, v-family integrins do not associate with Sdc1,
are not sequestered apart from 64 and their presence at the
basal surface of the cell may block phosphorylation of 64
integrin.
Loss of Sdc1 affects matrix assembly
Studies have shown that deposition of LN-332 is polarized, and
that 21 and 31 integrins regulate persistent migration in
keratinocytes (Nguyen et al., 2000; Frank and Carter, 2004), a
process that also involves formation of Rac1 gradients towards
the forward- or leading-edge during directed cell migration
(Pankov et al., 2005; Choma et al., 2004; Sehgal et al., 2006).
Whereas Sdc1-null cells show differences in migration rate, we
found no differences in their persistence indices on any of the
substrates tested.
In a model for the study of coronary infarcts, Sdc1-null mice
showed reduced deposition and increased disorder of collagens
after wounding, which was reversed when Sdc1-null mice were
infected with an adenovirus expressing Sdc1 before wounding.
Disorganized collagen contributed to cardiac dilatation and
reduced coronary function after infarcts in Sdc1-null mice
(Vanhoutte et al., 2007). Here, we show that keratinocytes
isolated from Sdc1-null mice also show reduced matrix
assembly. These are the same cultures at the same time point
that we also showed were synthesizing more of several
different collagen mRNAs. Defective matrix assembly in Sdc1null keratinocytes could be due to several factors; Vanhoutte
and colleagues (Vanhoutte et al., 2007) have suggested in their
heart model that elevated levels of MMP9 secreted by
inflammatory cells contribute to collagen degradation before
newly synthesized collagens had assembled into mature fibers.
Sdc1 has been shown to bind to and sequester proteases after
wounding in the skin (Bernfield et al., 1999) and, therefore,
defective proteolytic balance could contribute to matrix
destruction in vivo. Our data in vitro in the absence of
inflammatory cells suggests that the matrix assembly defect is
inherent in epithelial cells derived from the Sdc1-null mouse.
If shed Sdc1 extracellular domain serves to protect nascent
collagen molecules from destruction, its lack could lead to
denaturation and unfolding, which could alter the ability of the
matrix to support keratinocyte adhesion and migration.

The fact that the LN-332 tracks are better organized in the
Sdc1-null keratinocytes may result from the enhanced
adhesion-promoting activity of 64 integrin in these cells.
Whereas the LN-332 deposited by Sdc1-null cells was better
organized, the Sdc1-null cell matrix itself contained similar
amounts of LN-332 and was able to support robust migration
when wt keratinocytes were plated on it. TGF1 treatment of
wt keratinocytes increased cell-surface expression of integrins
but induced only modest increases in keratinocyte migration;
similar treatment of Sdc1-null keratinocytes had a marked
effect on migration rate, enhancing it significantly without
altering the overall levels of integrins on the Sdc1-null
keratinocyte surfaces. The mechanism whereby the Sdc1-null
keratinocytes increase their migration rate above those of
untreated wt cells after TGF1 treatment remains a subject of
ongoing investigation. We have shown here that the Sdc1-null
keratinocytes cease proliferating after TGF1 treatment with
the same dose-response as wt control keratinocytes but we do
not know whether or how long the wt and Sdc1-null cells
remain viable after they cease proliferating.
TGF1 can have differing affects on cell migration,
depending upon cell or tissue studied and integrins
expressed
Previous studies have shown conflicting results relating to the
affect of TGF1 signaling on epithelial cell migration. In
human keratinocytes, TGF1 increased migration rates
(Decline et al., 2003). In vivo skin-wound-healing
experiments using Smad3-null mice have shown accelerated
wound healing, suggesting that endogenous TGF1 signaling
impedes re-epithelialization after wounding (Ashcroft et al.,
1999). Transgenic mice overexpressing Smad2 have shown
delayed wound healing, again supporting the idea that
elevated TGF1 signaling delays healing in vivo (Hosokawa
et al., 2005). Other data have shown that neutralizing TGF1
in a wound-healing model that allows keratinocytes to
migrate as sheets after injury, accelerates sheet movement
(Neurohr et al., 2006). Experimental models for the study of
epithelial cell migration in vitro via sheet movement are
limited, but it appears that the differing mechanisms used by
v6 and v8 integrins to activate TGF1 at the cell
surface play important roles in relaying TGF1 signals from
outside to inside keratinocytes during sheet movement
(Sheppard, 2005).
By 3 days in culture, Sdc1-null keratinocytes have elevated
levels of v6, v8 and 64 on their surfaces, the same
integrins whose surface expression is enhanced when wt cells
are treated with TGF1. How epithelial integrins accumulate
at the surface of Sdc1-null keratinocytes is unclear. They could
accumulate as a result of the elevated constitutive TGF1
signaling, which acts to enhance integrin surface expression on
keratinocytes. Sdc-2 has recently been shown to mediate
TGF-induced fibrosis in a kidney cell culture model via a
mechanism that involved binding of Sdc2 with betaglycan, one
of the TGF receptors present on kidney cell surfaces (Chen
et al., 2004). The molecular mechanisms underlying syndecaninduced TGF affects are likely to vary in cell-type specific
ways, especially in epithelial and mesenchymal cells. Several
studies have implicated the Sdc1 cytoplasmic domain in
mediating endocytosis of cytokine receptors (Fuki et al., 2000;
Chen et al., 2004; Zimmermann et al., 2005), making it
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possible that the lack of Sdc1 alters integrin and growth-factorreceptor-mediated endocytosis (Caswell and Noman, 2006).
Such differences could account for aspects of both the cell
migration defects and enhanced responsiveness of the Sdc1null keratinocytes to TGF1.
Our data on Sdc1-null keratinocytes grown in vitro are
consistent with the hypothesis that the delayed corneal and skin
wound healing we reported previously in vivo (Stepp et al.,
2002) results from (1) the migrating Sdc1-null keratinocytes
being more adherent to their underlying matrix due to
increased adhesion promoting activity mediated by 64
integrin and, (2) altered responsiveness of the activated Sdc1null keratinocytes to TGF1 in their environment, which
increases surface expression of integrins and alters matrix
synthesis and deposition. The Sdc1-null keratinocytes produce
and secrete more active TGF1 in vitro. At the site of a wound,
TGF1 can be released by keratinocytes, mesenchymal cells
and by the inflammatory cells that are known to be present in
elevated numbers after wounding in Sdc1-null mice (Stepp et
al., 2002: Gotte and Echtermeyer, 2003; Neurohr et al., 2006).
Altered responsiveness of keratinocytes to TGF1 could affect
Sdc1-null keratinocyte migration rates by altering matrix
remodeling and reassembly. Additional studies on the effects
of the depletion of Sdc1 on signal transduction networks in
vivo in skin and cornea will shed light on the mechanisms
underlying the wound-healing defects induced by loss of this
important proteoglycan and, in doing so, provide insight into
the roles played by Sdc1 in forming and maintaining epithelial
tissues in health and disease.
Materials and Methods
Antibodies
For immunoblots and immunoprecipitations, we used the following antibodies
against: actin (Chemicon International, Temecula, CA; MAB1501R), v integrin
(Chemicon; AB1930), 5 integrin (Chemicon; AB1926), 6 integrin (Chemicon;
MAB2076Z), 8 integrin (Santa Cruz Biotechnology, Santa Cruz, CA; sc-10817),
2 integrin (Chemicon; AB1936), 5 integrin [BD Pharmingen, Franklin Lakes,
NJ; 5H10-27 (MFR5)], and LN-332 (Jonathan Jones, Northwestern University,
Chicago, IL). The 1, 4, 3 and 9 integrin antibodies were rabbit polyclonals
against cytoplasmic domain peptides (Sta Iglesia et al., 2000). For function blocking
of integrins, 25 g/ml each of the rat anti-mouse monoclonal antibodies 9EG7 for
1 integrin, GoH3 for 6 integrin and RMV-7 for v integrins were used. These,
along with an isotype-specific control IgGs were obtained from BD Pharmingen.
For immunofluorescence microscopy localization of integrins, the same antibodies
used for biochemical analyses listed above were used. For F-actin localization, we
used Alexa-Fluor-488-labeled phalloidin (Molecular Probes/Invitrogen, Carlesbad,
CA; A-12379), and for keratin-14, we used a rabbit polyclonal against mouse
keratin-14 (Covance Research Products, Princeton, NJ; PRB-155P). For flowcytometry analysis, we used the following antibodies: 6-FITC (BioLegend, San
Diego, CA; 313605), 1-phycoerythrin (PE) (BioLegend; 102207), and 4-PE
(Santa Cruz; sc-18883). For TGF1 neutralization studies, the antibody was
obtained from R&D Systems (Minneapolis, MN; AB-101-NA) and was used at 1
g/ml; a chicken polyclonal anti-vimentin antibody (Novus Biologicals, Littleton,
CO 80120) was used at the same dilution as a control.

Primary mouse keratinocyte cell culture
Wild-type (wt) mice (Balb/C) were obtained from NCI-Frederick (Frederick, MD).
Tissue culture media, stocks, and buffers were obtained from Gibco/Invitrogen
(Carlesbad, CA) unless otherwise indicated. Construction of Sdc1-deficient mice
has been described previously (Stepp et al., 2002); mice have been backcrossed into
a Balb/C genetic background (McDermott et al., 2007; Alexander et al., 2000).
Primary mouse keratinocytes were isolated from skin of newborn Balb/C or Sdc1null mice as described (Dlugosz et al., 1995), resuspended in freezing media (SMEM with 8% fetal calf serum (FCS), 1.4 mM calcium, 10% dimethylsulfoxide,
10 mM Hepes, pH 7.3) and stored in liquid nitrogen until use. For each experiment,
primary keratinocytes were grown in regular low-Ca2+ media (S-MEM and 8% FCS
with calcium concentration of 0.05 mM) for the times indicated. Tissue culture
plates were routinely coated with a mixture of human plasma fibronectin and
collagen I (FNCNI; 10 g/ml human plasma FN (BD Pharmingen, San Jose, CA);
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1% Vitrogen (v:v) and 100 g/ml bovine serum albumen (BSA) in S-MEM) for 15
minutes at 37°C prior to plating keratinocytes. For studies involving growth curves,
data are presented for adherent keratinocytes only.

Immunoblotting, flow cytometry and surface labeling using
biotinylation
Wt or Sdc1-null keratinocytes were cultured for 4 days. Medium was removed and
the keratinocytes were washed three times with PBS. Then, 250 l M-Per protein
extraction reagent (Pierce Chemical Company, Rockland, IL; 78503) with
proteinase inhibitor (1:100 dilution) (Pierce Chemical Co.; inhibitor cocktail,
78415) was added to each of the 10-cm cell culture dishes, and the keratinocytes
were harvested by scraping. A total of 10 g protein from each extract was loaded
to the 4-20% gel (Invitrogen, EC6025BOX) and SDS-PAGE electrophoresis was
performed at 140 V. Proteins were transferred to PVDF membrane (Millipore,
Billerica, MA; IPVH15150) at 300 mA for 1.5 hours, and the blot was then blocked
in blocking solution [Tris-buffered saline (TBS) with 0.1% Tween 20 (TBST) and
10% milk] overnight at 4°C. Blots were subjected to enhanced chemiluminescence
(ECL) reaction (Amersham/GE Healthcare Services, Piscataway NJ; RPN2132),
and chemiluminescence was detected using X-ray film. When appropriate, data
were quantified using NIH ImageJ software, v1.345 (available as a free download
at http://rsb.info.nih.gov/ij/).
For-flow cytometry, keratinocytes were trypsinized and resuspended in serumcontaining media, and concentrations were adjusted to normalize the cell counts for
wt and Sdc1-null keratinocytes. Per antibody tested, 200,000 keratinocytes were
spun down and resuspended in blocking buffer [PBS supplemented with 3% BSA
containing 1 l Fc-receptor (AbD Serotec, Raleigh, NC; BUF041A)]. Antibodies
used were conjugated directly with phycoerythrin (PE) and controls included
keratinocytes incubated with isotype-matched PE-conjugated antibodies, as well as
keratinocytes incubated in blocking buffer alone. For quantitation, FloJo software
(Windows Version 7.1.2, Tree Star, Inc., Ashland, OR) was used; median values for
fluorescence intensity were obtained for each experimental and control antibody,
and the ratios of experimental to control values obtained. Each determination was
performed a minimum of three times on three different cell preparations, and data
were tested for significance by Student’s t-test.
For biotinylation of cell surfaces, keratinocytes were grown in standard FNCNIcoated tissue culture dishes with standard 0.05 mM Ca2+ medium and harvested as
for the flow cytometry studies described above. Biotinylation was performed on
keratinocytes in suspension using EZ-Link NHS-Biotin (Pierce Chemical Co.;
20217) as recommended for labeling adherent keratinocytes, with the exceptions
that the biotin concentration was 0.5 mg/ml with PBS, and the reaction took place
at 4°C for 2 hours. After labeling, keratinocytes were washed twice in PBS, their
proteins extracted, and integrins were immunoprecipitated as described in Stepp et
al., (Stepp et al., 1990). The efficiency of biotinylation was followed by running 50
and 100 ng extract of total biotinylated protein from wt and Sdc1-null cells,
transferring the proteins to filters, and detecting biotin using horse radish peroxidase
(HRP)-conjugated avidin (Bio-rad, Hercules, CA; 170-6528). For all of the data
presented, the biotinylation efficiencies were confirmed to be similar between wt
and Sdc1-null keratinocytes.

Immunofluorescence
For immunofluorescence microscopy, keratinocytes were routinely grown on glass
well chamber slides (Lab Tek II Chamber Slide System, 154526, Nalge Nunc
International Corp., Naperville IL) that had been precoated with FNCN1 for 3 hours
at 37°C as described above. After 3 days, the keratinocytes were fixed in ice-cold
50% methanol and 50% acetone for 2 minutes followed by 20 minutes in 100%
methanol and, storage in PBS. Immunofluorescence was performed as described
previously (Stepp et al., 2002).

Cell adhesion and spreading studies
For cell adhesion and spreading studies, s wt and Sdc1-null keratinocytes that had
been cultured for 3-4 day were released by incubation in trypsin for 8 minutes.
Trypsin activity was inhibited by addition of serum, and keratinocytes were
resuspended in 0.2% serum-containing low-Ca2+ (0.05 mM) medium. Cell adhesion
studies were performed using the CytoMatrix Screening Kit (Chemicon, ECM205),
as recommended by the manufacturer. Cell spreading was determined at 15 and 45
minutes after plating keratinocytes onto either FNCNI or LN5/LN-332 (Aumailley
et al., 2005) obtained from conditioned media of 804G cells (Hormia et al., 1995;
Baker et al., 1996), a gift from Jonathan C. Jones (Northwestern University,
Chicago, IL). Keratinocytes were fixed with 2% paraformaldehyde for 15 minutes,
permeabilized with 0.1% Triton X-100 for 20 minutes, and stained with an antibody
against actin. After visualization of the actin-stained cells using Alexa-Fluor-488conjugated secondary antibody (Molecular Probes/Invitrogen), low-magnification
images were obtained. Areas of no fewer than 100 keratinocytes were determined
using Image Pro Plus software (Media Cybernetics, Silver Spring, MD),
experiments were performed three times, and data expressed in arbitrary units.

Time-lapse-microscopy studies
Keratinocytes were seeded on 24-well plates and allowed to grow for 3 days before
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imaging on an Olympus IX81 research microscope (Olympus America, Melville,
NY), equipped with a Proscan motorized stage (Prior Scientific Instruments Ltd.,
Rockland, MA) and placed in a temperature- and CO2-controlled chamber (LiveCell
Incubation System, Neue Biosciences, Camp Hill, PA). Using relief-contrast optics,
10 images were taken of each well every 10 minutes (for 16 hours, 40 minutes)
until 100 images were captured. For each variable, triplicate wells were tracked and
images managed using Slidebook 4.0 Digital Microscopy Solutions software
(Intelligent Imaging Inovations, Denver, CO). Images were transferred to a
workstation equipped with Metamorph image analysis software (Molecular Devices
Corp., Chicago, IL), where velocities were calculated using the track cell module.
Per well, 10-20 keratinocytes were tracked over the entire time period. A Visual
Basic program was written by one of the co-authors (LJ) to allow us to choose the
keratinocytes to track randomly from each field and to assist in data analysis. From
each cell tracked, an average velocity was calculated. To verify that there was no
change in velocity over time for each experiment, velocity over time was routinely
assessed for each cell tracked. For experiments involving measurement of cell
velocity on prepared wt and Sdc1-null cell matrices, wt and Sdc1-null keratinocytes
were initially plated out onto both 100-mm dishes (for harvesting) and 24-well
plates (for tracking). After 3 days, keratinocytes were harvested from 100-mm
dishes by trypsinization and replated in triplicate onto 24-well plates coated with
FNCNI or LN-332. For matrix swapping experiments, triplicate wells of wt or Sdc1null keratinocytes grown in 24 well plates were lysed for 10 minutes at room
temperature using 0.02 M ammonium hydroxide as described by deHart and
colleagues (deHart et al., 2003), wells were washed three times with PBS to
neutralize the solution and remove cellular debris, and matrices were seeded with
the harvested keratinocytes. Whenever matrix swapping was performed, control
wells containing wt and Sdc1-null keratinocytes grown for 3 days but not trypsinized
were also tracked to provide internal controls for each experiment. After replating,
keratinocytes were allowed to adhere for 1 hour. Non-attached keratinocytes were
then removed and medium was added. Keratinocytes were then allowed to acclimate
in the 37°C incubator for 2 hours prior to initiation of tracking. For studies using
TGF1 neutralizing antibodies, keratinocytes were grown overnight in media
supplemented with the antibody and tracked the next day. For studies using integrinfunction-blocking antibodies, antibodies were added and keratinocytes tracked
overnight; however, velocity data were derived from keratinocytes during the first
6 hours after integrin-neutralizing antibodies were added.

Sirius Red dye binding assay
This assay was performed as described by Heng and colleagues (Heng et al., 2006).
After cell tracking, cells within the wells of 24-well plates were fixed with Bouin’s
Fixative (75 ml of a saturated solution of picric acid (Sigma-Aldrich cat. number
319287), 20 ml formaldehyde, and 5 ml glacial acetic acid) for 1 hour, washed, and
wells dried in a 42°C oven for 15 minutes; 0.5 ml Sirius Red staining solution was
added to each well [0.25 gm Sirius Red (direct red 80, Sigma Aldrich cat. number
365548) in 250 ml picric acid] and cells incubated in the hood for 60 minutes while
shaking gently. Wells were washed with water, washed again with acid water (0.01
N HCl), and dried in a 42°C oven for 15 minutes. Bound Sirius Red dye was eluted
with 250 l of 0.1N NaOH and collagen accumulation per well we determined by
measuring the OD of the eluted dye at 550 nm. After elution of the Sirius Red dye,
wells were washed once again, dried, and cell counts determined using a crystal
violet dye binding assay to allow the collagen accumulated in each well to be
normalized for differences in cell number.

biglycan Fw 5-GACAACCGTATCCGCAAAGT-3, Re 5-GTGGTCCAGGTGAAGTTCGT-3; CN4 1 Fw 5 ATTTCCCCGCCGTCTCTGCTGGTC-3, Re 5GGTCCCCTCGTCCCTTTTGTGC-3; CN4 2 Fw 5-GCCAGGCCGCAGTGTGAG-3, Re 5-CAGCCGGGCAGTGGGGTAT-3; CN5 1 Fw 5-GGCCGCTCCCCTGTCTTC-3, Re 5-AGTCGGGGCTGTAGTGCTCA-3; mouse CN62 Fw
5-AGAAGCGCTGTGGTGCCCTGGATG-3, Re 5-CTGGCGCCGGCTTTCTTTGATGAG-3; mouse decorin Fw 5-TGAGCTTCAACAGCATCACC-3, Re 5AAGTCATTTTGCCCAACTGC-3; mouse EGF Receptor I Fw 5-CGCGAGAACCACACTGCTGGTGT-3, Re 5-TAGTATCCATATTGCAGAGGATG-3;
fibromodulin Fw 5-CTGCTTCTGCAGTTGCTCTG-3, Re 5-GGTGTGGGTGTCTCCTGACT-3; mouse lumican: Fw 5-AAGAGTGTGCCAATGGTTCC-3,
Re 5-GGACTCGGTCAGGTTGTTGT-3; mouse smad7 Fw 5-TGGCATACTGGGAGGAGAAGAC-3, Re 5-CACGTCTAGTCGAAACACTTCC-3; mouse
thrombospondin Fw 5-GAACCAGCTGAGCAAGAACC-3, Re 5-CAGGTGAGCAGGTGATCTGA-3; mouse TGF-1: Fw 5-GAAAGCGGCAACCAAATC3, Re 5-TGACATCAAAGGACAGCCAC-3; mouse TGF  Receptor I Fw 5ACCTTCTGATCCATCGGTTG-3, Re 5-TTCCTGTTGGCTGAGTTGTG-3;
mouse TGF Receptor II Fw 5-GCAAGTTTTGCGATGTGAGA-3, Re 5GGCATCTTCCAGAGTGAAGC-3.
For the Smad4 dual-reporter assay, wt and Sdc1-null keratinocytes were grown
in 24-well plates and, after 3 days in culture, were transiently transfected
simultaneously with one plasmid driving expression of firefly luciferase under a
SMAD4 promoter (pSBE4-luc) and a second plasmid driving expression of a
Renilla (sea pansy) luciferase under a transketolase promoter (pRL-TK-luc) to serve
as an internal control for transfection efficiency. After 2 days, wt and Sdc1-null
keratinocytes were treated in triplicate with different concentrations of TGF1 for
6 or 24 hours. The ratio of firefly luciferase to Renilla luciferase was determined
using Stop and Glo Dual-Luciferase Reporter Assay System (Promega, E1910) and
the fold increase in TGF1-mediated transcription was calculated as a function of
the concentration of TGF1 added to the keratinocytes in culture.
The cessation of cell proliferation after TGF1 addition was determined as
previously described (Vijayachandra et al., 2003). In brief, at both 4 and 7 days in
culture, tritiated thymidine was added to keratinocytes after 24-hour treatment with
varying concentrations of TGF1, ranging from 0-1.0 ng/ml. The incorporation of
radioactivity into DNA was assessed. Data are expressed as the percentage of
radioactive counts incorporated per well after addition of TGF1, relative to
incorporation of radioactivity in keratinocytes that had no exogenous TGF1 added.
For experiments involving the use of added TGF1 for time-lapse or Smad
phosphorylation studies, TGF1 was added at a concentration of 0.25 ng/ml unless
otherwise indicated. The antibody used to detect Smad2 phosphorylation was
directed against the Ser465-Ser467 residue of Smad2 (cat. number 3101, Cell
Signaling Technology, Inc., Danvers, MA 01923).
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TGF1 studies
For determination of total TGF1 in conditioned media, keratinocytes were seeded
onto 100-mm culture dishes and cultured for the indicated times, after which they
were washed twice with PBS and then incubated with serum-free S-MEM
containing 0.05 mM Ca2+, for 24 hours. Cell debris was removed by centrifugation
and conditioned medium, and stored at –70°C. After conditioned medium was
harvested, the number of keratinocytes present per dish was counted. TGF1 levels
in the conditioned medium were determined after acid activation by sandwich
ELISA (R&D Systems; TGF1-Quantikine-DB100B).
For determination of TGF1 activity, transfected mink lung epithelial cells
(TMLCs) carrying the of promoter plasminogen activator inhibitor 1 (PAI-1) driving
expression of firefly luciferase were used as described (Mazzieri et al., 2000).
TMLCs were plated into 24-well plates and, after reaching confluence, were treated
with the conditioned medium harvested above. Relative luciferase expression in the
TMLCs was determined using the Luciferase Assay System (Promega, Madison,
WI; E1500).
For semi-quantitative RT-PCR, total RNA was purified from cultured wt or Sdc1null keratinocytes using Trizol (Invitrogen, cat. number 15596-026). RNA pellets
were re-suspended in DEPC-treated water and concentrations determined. Reverse
transcription was performed using SuperScript First-Strand Synthesis System
(Invitrogen, cat. number 11904-018) according to the manufacturer’s instructions.
The optimal number of cycles for a particular mRNA was determined so that the
reaction product was in the linear range of the product-cycle curve to ensure that
the amount of the PCR product reflected the amount of the cDNA and, thus, the
mRNA. cDNAs were amplified using the following primer sequences: mouse
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